Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001321543-06-000158
Filing Date
2006-03-31
Accepted
2006-03-31 16:43:40
Documents
8
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT FOR YEAR ENDED 12-31-2005 maindoc.htm 10-K 1851335
2 PATENT AND TECHNOLOGY LICENSE AGREEMENT ex10-22.htm EX-10.22 222163
3 LIST OF SUBSIDIARIES ex-21.htm EX-21 2618
4 CONSENT OF BDO SEIDMAN, LLP ex23.htm EX-23 4354
5 CERTIFICATION ex31-1.htm EX-31.1 10984
6 CERTIFICATION ex31-2.htm EX-31.2 10844
7 CERTIFICATION ex32-1.htm EX-32.1 5906
8 CERTIFICATION ex32-2.htm EX-32.2 5999
  Complete submission text file 0001321543-06-000158.txt   2115729
Mailing Address 420 LEXINGTON AVENUE SUITE 601 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 601 NEW YORK NY 10170 2126729190
CALLISTO PHARMACEUTICALS INC (Filer) CIK: 0001142380 (see all company filings)

EIN.: 651107840 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32325 | Film No.: 06729502
SIC: 2834 Pharmaceutical Preparations